Science Corporation

Building a brighter tomorrow enabled by neural engineering

[Science Corporation @ScienceCorp_]

Science CEO, Max Hodak will join @handelsblatt's @FelixHoltermann at TECH by Handelsblatt, Europe's premier conference for technology, innovation, and future business models, on Monday to discuss the future of brain-computer interfaces.

Max recently spoke with Handelsblatt about our PRIMA retinal implant, the first treatment to restore vision in clinical trials for certain patients with advanced geographic atrophy associated with age-related macular degeneration.

https://t.co/1Qw59yGtHV

[Science Corporation @ScienceCorp_]

Learn more: https://t.co/Xtg6uKhqKx

[Science Corporation @ScienceCorp_]

Our team working on the next-generation PRIMA Glasses is focused on creating the best patient experience. How? By leveraging the “smartphone dividend.” Watch.

[Science Corporation @ScienceCorp_]

Check out https://t.co/8NcwissvTz. We are hiring.

[Science Corporation @ScienceCorp_]

At Science, our cell engineers create neurons from stem cells. See what it looks like.

[Science Corporation @ScienceCorp_]

“Max Hodak is working on the future … The first practical test for this goal is a product called ‘PRIMA’—a microchip smaller than a grain of rice that is implanted not in the brain, but under the retina.”

Science CEO, @maxhodak_, spoke with @handelsblatt about our PRIMA retinal implant, the first treatment to restore vision in clinical trials for certain patients with advanced geographic atrophy associated with age-related macular degeneration.

https://t.co/1Qw59yFVSn

[Science Corporation @ScienceCorp_]

What key principles should govern the rights of BCI patients? Our Chief Legal Officer Alex Feerst wrote about it here https://t.co/WvDi8UIhVP. Today he is joined by Science's Director of BCI Research Emma Zhou at The Cognitive Frontier in San Francisco to discuss.

[Science Corporation @ScienceCorp_]

Learn more about Science Foundry: https://t.co/c3t9egNZiS

[Science Corporation @ScienceCorp_]

Construction is underway at our updated Science Foundry facility in Durham, NC for the manufacture of next-generation BCI devices.

[Science Corporation @ScienceCorp_]

Prof. Boris Stanzel (Eye Clinic Sulzbach, Knappschaft Hospital Saar & Department of Ophthalmology, University of Bonn) presenting at ARVO 2026 (Association for Research in Vision and Ophthalmology) delivered one of ten PRIMA presentations ("Utility of the Intraoperative OCT during Subretinal Implantation of the PRIMA Retina Implant in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration") exploring the role of real-time OCT imaging during subretinal implantation, drawing on the PRIMA clinical trial.

[Science Corporation @ScienceCorp_]

Learn more: https://t.co/Xtg6uKhqKx

[Science Corporation @ScienceCorp_]

ARVO brings together the world's leading vision researchers and clinicians each year. This week, PRIMA by Science was featured in ten presentations across clinical outcomes, device training, surgical technique, and imaging.

[Science Corporation @ScienceCorp_]

Learn more:
https://t.co/NoqhqBrl48

[Science Corporation @ScienceCorp_]

What does it take to engineer a smaller, lighter, and more ergonomic PRIMA? Watch Episode 1: Our team tackles the next generation PRIMA Glasses.

[Science Corporation @ScienceCorp_]

Congratulations to José-Alain Sahel, MD, co-senior author of the PRIMA clinical trial, on receiving the 2026 Proctor Medal from the Association for Research in Vision and Ophthalmology, one of the highest honors in vision research.

This morning at ARVO, Prof. Sahel delivered the Proctor Award Lecture, "Shooting in the Dark, a Translational Odyssey," tracing decades of gene-independent approaches to protect and restore vision in retinal degeneration, including retinal implants.

[Science Corporation @ScienceCorp_]

New clinical and preclinical data on PRIMA by Science will be presented at the Association for Research in Vision and Ophthalmology (ARVO) 2026 annual meeting in Denver this weekend across ten sessions:

May 5 — Daniel Palanker, Ava Bittner, Ralf Hornig, Frank Brodie, Boris Stanzel
May 6 — Martina Corazzol, José-Alain Sahel, Keith Ly
May 7 — Lisa Olmos De Koo, Sebastian Trinh Lee

[Science Corporation @ScienceCorp_]

Teams from five universities used the Science Ecosystem to recreate the BCI loop in a single weekend. Watch what happens:

[Science Corporation @ScienceCorp_]

Come see a special preview of the next-generation PRIMA glasses at the Potsdam Meeting 2026 from April 17–18.

The new glasses are updated for functionality, including integrated processing and eye tracking.

Stop by our Science booth to connect with our team and learn more about the PRIMA system for GA/AMD.

[Science Corporation @ScienceCorp_]

@TechCrunch's @TimFernholz reports: “Max Hodak’s Science Corp. is preparing to place its first sensor in a human brain.” Science Advisor Dr. Murat Günel says: “The idea of using natural connections through neurons and creating a biological interface between the electronics and the human brain is genius.”

https://t.co/m3oM0yAu7u

[Science Corporation @ScienceCorp_]

Come visit us at the VM Retina Meeting 2026 in Munich from Thurs, April 16 – Sat, April 18 – booth #7.

Meet our team and see the PRIMA implant, next-gen glasses, and implantation device up close.

PRIMA is our fully wireless, photovoltaic retinal implant which in clinical trials restored central vision to patients with geographic atrophy due to age-related macular degeneration. In a landmark clinical trial published in the New England Journal of Medicine, ~80% of participants demonstrated clinically meaningful improvement in visual acuity at 12 months, and 84% reported the ability to read letters, numbers, and words.